US FDA Grants Spectral Medical Breakthrough Device Designation for Toraymyxin™ (“PMX”) for the Treatment of Endotoxemic Septic Shock
July 11, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, July 11, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
June 21, 2022 16:20 ET
|
Spectral Medical Inc.
TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral and Dialco Announce Dr. John Kellum to be Featured as Keynote Lecturer at the 40th Vicenza Course on AKI and CRRT 2022
June 14, 2022 07:30 ET
|
Spectral Medical Inc.
TORONTO, June 14, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Adoption of SAMI Device by the Largest Inpatient Dialysis Provider in South Florida
June 13, 2022 07:30 ET
|
Spectral Medical Inc.
TORONTO, June 13, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Appointment of Leading Industry Executive Sam Amory as Dialco President
May 16, 2022 07:30 ET
|
Spectral Medical Inc.
TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Announces First Quarter Results and Provides Corporate Update
May 13, 2022 07:30 ET
|
Spectral Medical Inc.
TORONTO, May 13, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Announces Fourth Quarter and Fiscal 2021 Results and Corporate Update
March 24, 2022 07:30 ET
|
Spectral Medical Inc.
TORONTO, March 24, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Announces Appointment of Blair McInnis as CFO
March 21, 2022 07:30 ET
|
Spectral Medical Inc.
TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
Dialco Medical Announces Formation of Medical Advisory Board to Support the Continued Development of DIMI Device
March 16, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly owned subsidiary, Dialco Medical Inc. (“Dialco”), has...
Spectral Medical CMO Dr. John Kellum to Present at the 27th International AKI & CRRT Conference on March 7-10, 2022
March 04, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, March 04, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...